Telomerase targeted therapy in cancer and cancer stem cells.
暂无分享,去创建一个
A. Goldkorn | Amir Goldkorn | Yucheng Xu | Kaijie He | Yucheng Xu | K. He
[1] Z. Tao,et al. Alternative lengthening of telomeres in hTERT‐inhibited laryngeal cancer cells , 2010, Cancer science.
[2] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[3] S. Spiegl-Kreinecker,et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes , 2003, Melanoma research.
[4] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[5] William C Hahn,et al. Establishment : adaptation to culture and immortalization , 2002 .
[6] K. Collins. The biogenesis and regulation of telomerase holoenzymes , 2006, Nature Reviews Molecular Cell Biology.
[7] O. Nanni,et al. Relevance of urine telomerase in the diagnosis of bladder cancer. , 2005, JAMA.
[8] R. Weinberg,et al. Cancer stem cells: mirage or reality? , 2009, Nature Medicine.
[9] M. Manns,et al. A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma , 2010, BMC Cancer.
[10] J. Yates,et al. Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell‐Containing Side Population , 2008, Stem cells.
[11] Stephen Neidle,et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. , 2005, Cancer research.
[12] E. Blackburn,et al. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. DeMichele,et al. Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. , 2007, Cancer research.
[14] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[15] J. Hipp,et al. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[17] M. Oshimura,et al. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas , 1998, Journal of Cancer Research and Clinical Oncology.
[18] C. Harley,et al. A novel telomerase template antagonist (GRN163) as a potential anticancer agent. , 2003, Cancer research.
[19] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.
[20] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[21] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[22] J. Shay,et al. Telomerase activity in gastric cancer. , 1995, Cancer research.
[23] C. Harley,et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. , 2010, Cancer research.
[24] D. Bearss,et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] Donna Niedzwiecki,et al. Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1 , 2005, The Journal of Immunology.
[26] Lingjun Meng,et al. Tumor-initiating function of nucleostemin-enriched mammary tumor cells. , 2010, Cancer research.
[27] Masaharu Akiyama,et al. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells. , 2007, Cancer letters.
[28] J. Kigawa,et al. Alteration of Telomerase Activity Associated With Development and Extension of Epithelial Ovarian Cancer , 1998, Obstetrics and gynecology.
[29] T. Lange. Lasker Laurels for Telomerase , 2006, Cell.
[30] M. Robinson,et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. , 1999, Genes & development.
[31] H. Kato,et al. Telomerase activity in lung cancer cells obtained from bronchial washings. , 1998, Journal of the National Cancer Institute.
[32] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[33] Hailong Wu,et al. Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype , 2010, Molecular Cancer Therapeutics.
[34] J. Shay,et al. The effects of telomerase inhibition on prostate tumor‐initiating cells , 2010, International journal of cancer.
[35] Chun-Peng Liao,et al. Reprogramming Murine Telomerase Rapidly Inhibits the Growth of Mouse Cancer Cells In vitro and In vivo , 2010, Molecular Cancer Therapeutics.
[36] H. Eguchi,et al. In Situ Telomerase Activity in Pancreatic Juice May Discriminate Pancreatic Cancer From Other Pancreatic Diseases , 2008, Pancreas.
[37] H. Stein,et al. Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTR , 2002, The Journal of pathology.
[38] D. Amadori,et al. Potential of telomerase expression and activity in cervical specimens as a diagnostic tool , 2005, Journal of Clinical Pathology.
[39] K. Chayama,et al. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere‐targeting anticancer drug development , 2010, Cancer science.
[40] W. Hahn,et al. Roots and stems: stem cells in cancer , 2006, Nature Medicine.
[41] J. Marks,et al. Telomerase activity and prognosis in primary breast cancers. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] A. Krešo,et al. Cancer stem cells in solid tumors: an overview. , 2009, Seminars in radiation oncology.
[43] Stephen Lam,et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.
[44] N. Maizels,et al. Gene function correlates with potential for G4 DNA formation in the human genome , 2006, Nucleic acids research.
[45] R. Stewart,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[46] S. Aamdal,et al. Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer , 2006, Cancer Immunology, Immunotherapy.
[47] B. Hero,et al. Telomerase activity distinguishes between neuroblastomas with poor prognosis , 1999 .
[48] I. Svane,et al. Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. , 2010, Cytotherapy.
[49] J. Londoño-Vallejo,et al. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA. , 2009, Cancer letters.
[50] H. Niiyama,et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] K. Collins,et al. Specificity and Stoichiometry of Subunit Interactions in the Human Telomerase Holoenzyme Assembled In Vivo , 2010, Molecular and Cellular Biology.
[52] Ruth I. Tennen,et al. Conditional telomerase induction causes proliferation of hair follicle stem cells , 2005, Nature.
[53] B. Gilchrest,et al. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells , 2007, Breast Cancer Research.
[54] S. Litvinov,et al. The biology of the 17–1A antigen (Ep-CAM) , 1999, Journal of Molecular Medicine.
[55] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[56] J. Burdick,et al. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. , 1998, Gastrointestinal endoscopy.
[57] J. Shay,et al. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. , 2001, Nucleic acids research.
[58] J. Shay,et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[59] E. Blackburn,et al. Rapid Inhibition of Cancer Cell Growth Induced by Lentiviral Delivery and Expression of Mutant-Template Telomerase RNA and Anti-telomerase Short-Interfering RNA , 2004, Cancer Research.
[60] K. Shin‐ya,et al. (S)-stereoisomer of telomestatin as a potent G-quadruplex binder and telomerase inhibitor. , 2011, Organic & biomolecular chemistry.
[61] M. Tan,et al. Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma. , 2011, Blood.
[62] A. Cesario,et al. Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. , 2009, Current medicinal chemistry.
[63] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[64] G. Z. Cheng,et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.
[65] K. Collins,et al. A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.
[66] E. Maher,et al. The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth , 2010, Clinical Cancer Research.
[67] J. Shay,et al. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. , 2002, Differentiation; research in biological diversity.
[68] A. Marchetti,et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[69] A. Meeker,et al. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. , 2006, Urologic oncology.
[70] A. Goldkorn,et al. Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype , 2011, Molecular Cancer Therapeutics.
[71] T. Lange,et al. Shelterin: the protein complex that shapes and safeguards human telomeres , 2005 .
[72] Alessandro Lugli,et al. Frequent EpCam protein expression in human carcinomas. , 2004, Human pathology.
[73] E. Gilson,et al. G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors , 2008, Clinical Cancer Research.
[74] J. Shay,et al. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts , 1989, Molecular and cellular biology.
[75] J. Shay,et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. , 1997, Journal of the National Cancer Institute.
[76] Robin C. Allshire,et al. Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.
[77] J. Shay,et al. Telomerase activity as a marker of breast carcinoma in fine‐needle aspirated samples , 2000, Cancer.
[78] M. Cerone,et al. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability , 2001, Oncogene.
[79] Bo Lu,et al. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. , 2010, Cancer research.
[80] I. Dokal,et al. Dyskeratosis congenita: a genetic disorder of many faces , 2007, Clinical genetics.
[81] Haruo Tanaka,et al. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. , 2010, Anticancer research.
[82] S. Neidle,et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.
[83] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[84] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[85] J. Griffith,et al. Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.
[86] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.
[87] R. DePinho,et al. Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.
[88] M. Maitland,et al. A phase I trial of GRN163L (GRN), a first-in-class telomerase inhibitor, in advanced solid tumors , 2008 .
[89] E. Blackburn,et al. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.
[90] E. Blackburn,et al. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis , 1989, Nature.
[91] R. Wurm,et al. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments , 1999, Oncogene.
[92] E. Blackburn,et al. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells. , 2008, Cancer research.
[93] C. Streutker,et al. Telomerase Activity as a Prognostic Factor in Neuroblastomas , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[94] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[95] C. Osborne,et al. Telomerase activity and survival of patients with node-positive breast cancer. , 1997, Journal of the National Cancer Institute.
[96] S. Rosenberg,et al. Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase , 2004, Clinical Cancer Research.
[97] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[98] K. Fox,et al. Phase I study of anti-CD25 mab daclizumab to deplete regulatory T cells prior to telomerase/survivin peptide vaccination in patients (pts) with metastatic breast cancer (MBC). , 2010 .
[99] Raina A Tamakawa,et al. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner. , 2010, Cancer research.
[100] K. Shin‐ya,et al. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. , 2006, Cancer research.
[101] G. Nelson,et al. ssDNA fragments induce cell senescence by telomere uncapping , 2008, Experimental Gerontology.
[102] Ming-ming Zhang,et al. Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation. , 2007, World journal of gastroenterology.
[103] A. Smogorzewska,et al. Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.
[104] G. Mills,et al. Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[105] J. Nemunaitis,et al. A randomized phase III study of gemcitabine (G) versus GV1001 in sequential combination with G in patients with unresectable and metastatic pancreatic cancer (PC). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[106] J. Feigon,et al. Quadruplex structure of Oxytricha telomeric DNA oligonucleotides , 1992, Nature.
[107] J. Shay,et al. Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors , 2002, Oncogene.
[108] N. Bache,et al. Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.
[109] Hamid Morjani,et al. Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells* , 2006, Journal of Biological Chemistry.
[110] J. D. Watson. Origin of Concatemeric T7DNA , 1972 .
[111] W. Hahn,et al. Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes , 2004, Clinical Cancer Research.
[112] B. Gilchrest,et al. Induction of apoptosis by telomere 3' overhang-specific DNA. , 2002, Experimental cell research.
[113] S. Scott,et al. Cancer stem cells - from initiation to elimination, how far have we reached? (Review). , 2009, International journal of oncology.
[114] K. Collins. Physiological assembly and activity of human telomerase complexes , 2008, Mechanisms of Ageing and Development.
[115] E. Raymond,et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[116] E. Blackburn,et al. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. , 2006, Cancer research.
[117] A. Goldkorn,et al. Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference , 2011, The Prostate.
[118] W. Hahn,et al. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. , 1999, Immunity.
[119] J. Shay,et al. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. , 2005, Cancer research.
[120] K. Shin‐ya,et al. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3′ telomeric overhang in cancer cells , 2006, Oncogene.
[121] M. Kudo,et al. Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma , 2007, Oncology.
[122] G. Sledge,et al. Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). , 2010 .
[123] E. Blackburn,et al. Telomere states and cell fates , 2000, Nature.
[124] H. Körner,et al. Metachronous cancer development in patients with sporadic colorectal adenomas—multivariate risk model with independent and combined value of hTERT and survivin , 2008, International Journal of Colorectal Disease.
[125] Timothy D. Veenstra,et al. A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis , 2009, Science.
[126] N. Senzer,et al. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[127] Keiko Hiyama,et al. Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.
[128] M. Eller,et al. Telomere‐based DNA damage responses: a new approach to melanoma , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[129] R. Reddel,et al. Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.
[130] Jialing Yuan,et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. , 2007, Cancer research.
[131] Laurence H. Hurley,et al. Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents , 2005, Nucleic acids research.
[132] K. Kapila,et al. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. , 2001, Lung cancer.
[133] F. Millard,et al. Phase I study of transgenic B lymphocyte immunization (TLI) against telomerase in androgen-independent prostate cancer (PC). , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[134] M. Cerone,et al. Telomere maintenance by telomerase and by recombination can coexist in human cells. , 2001, Human molecular genetics.
[135] L. Hu,et al. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant , 2010, British Journal of Cancer.
[136] I. Ganly,et al. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase , 2003, Oncogene.
[137] K. Hioki,et al. Change in telomerase activity during human colorectal carcinogenesis. , 1999, Anticancer research.
[138] A. Uchida,et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors , 2002, Cancer.
[139] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[140] Carlo Leonetti,et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. , 2007, The Journal of clinical investigation.
[141] Robert A. Weinberg,et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[142] S. Aamdal,et al. A phase I/II study of telomerase peptide vaccination in combination with chemotherapy in patients with stage IV malignant melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[143] T. Płusa,et al. Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival. , 2008, Lung cancer.
[144] Ian A. White,et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.
[145] A. Protopopov,et al. Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo , 2008, Leukemia.
[146] B. Murphy,et al. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity , 2004, Cancer Gene Therapy.
[147] N. Maitland,et al. Prostate cancer stem cells: a new target for therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[148] T. Płusa,et al. Telomerase activity in transthoracic fine needle biopsy aspirates as a marker of peripheral lung cancer , 2007, Thorax.
[149] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[150] J. Shay,et al. Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. , 1998, International journal of molecular medicine.
[151] E. Blackburn,et al. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs , 1990, Nature.
[152] I. Weissman,et al. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[153] R. Crevoisier,et al. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[154] R. Verdun,et al. Replication and protection of telomeres , 2007, Nature.
[155] Amy Lin,et al. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. , 2009, Cancer research.